LEADER 03528oam  2200673I  450 
001 9910826864403321
005 20240402053942.0
010   $a1-317-73375-4
010   $a1-315-79085-8
010   $a1-317-73376-2
024 7 $a10.4324/9781315780855 
035   $a(CKB)2670000000518878
035   $a(EBL)1619373
035   $a(SSID)ssj0001174272
035   $a(PQKBManifestationID)11977475
035   $a(PQKBTitleCode)TC0001174272
035   $a(PQKBWorkID)11107689
035   $a(PQKB)10820300
035   $a(OCoLC)874172833
035   $a(MiAaPQ)EBC1619373
035   $a(OCoLC)897457634
035   $a(EXLCZ)992670000000518878
100   $a20180706d2013      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aInternational strategy and market performance in new biotechnology firms /$fJoseph E. Coombs
205   $a1st ed.
210  1$aNew York :$cRoutledge,$d2013.
215   $a1 online resource (111 p.)
225 0 $aTransnational business and corporate culture
300   $aDescription based upon print version of record.
311   $a1-138-97293-2 
311   $a0-8153-3501-6 
320   $aIncludes bibliographical references and index.
327   $aCover; Transnational Business and Corporate Culture; Title Page; Copyright Page; Dedication; Table of Contents; Preface; Acknowledgments; List of Tables and Figures; Chapter 1 Introduction; Chapter 2 Theory and Hypotheses; Biotechnology Research; Literature Review: International Entrepreneurship; Literature Review: Organizational Change; Hypotheses; Chapter 3 Methodology; Research Design; Sample Selection; Measures of Constructs, Model I; Measures of Constructs, Model II; Measures of Constructs, Model III; Chapter 4 Analysis and Results; Data Analysis; Descriptive Statistics
327   $aDirection of Change in International StrategyForeign Revenue as a Percentage of Total Revenue; Firm Market Value; Chapter 5 Discussion and Conclusions; Discussion of Results; Limitations of the Study; Future Research; Appendix A Firms Included in Study; Appendix B Sample Coding Sheet; References; Index
330   $aThe issues addressed in this study are: What internal factors support changes in the international operations of new firms? and What effect do these changes have on the firm's structure, control system, and market performance.To answer these questions, this work examines the internal resources and market performance of a set of publicly traded biotechnology firms. Findings support the view that new firms can enter international markets through a variety of strategies, including international joint ventures and subsidiaries. Changes in international operations also are found to enhance firm
410  0$aTransnational Business and Corporate Culture
606   $aBiotechnology industries
606   $aNew business enterprises
606   $aInternational business enterprises
606   $aInternational trade
615  0$aBiotechnology industries.
615  0$aNew business enterprises.
615  0$aInternational business enterprises.
615  0$aInternational trade.
676   $a338.4/76606
676   $a338.476606
700   $aCoombs$b Joseph E.$f1966-,$01617656
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910826864403321
996   $aInternational strategy and market performance in new biotechnology firms$93948937
997   $aUNINA